Walleye Capital’s Signify Health, Inc. SGFY Stock Holding History

Walleye Capital’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-51,883	Closed	-$1.49M	–	4563
2022 Q4	$1.49M	Buy	51,883 +1,159	+2%	+$33.5K	0.03%	744
2022 Q3	$1.48M	Buy	+50,724	New	+$1.17M	0.03%	712
2022 Q2	–	Sell	-22,797	Closed	-$414K	–	2822
2022 Q1	$414K	Buy	+22,797	New	+$327K	0.01%	1113

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Walleye Capital's SGFY Position: Q1 2023 in Review

Walleye Capital sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 51,883 shares — an estimated $1.49M sold.

Walleye Capital first reported a position in SGFY in Q1 2022 and held it in 3 quarters. The position peaked at $1.49M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

Walleye Capital reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 51,883 Signify Health, Inc. shares in Q1 2023, an estimated $1.49M.
Walleye Capital first reported a position in Signify Health, Inc. in Q1 2022 and held it in 3 quarters.
Walleye Capital's Signify Health, Inc. position peaked at $1.49M in Q4 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.